Results 191 to 200 of about 269,022 (329)

Ocular Electrophysiology

Delhi Journal of Ophthalmology, 2015
Pooja Jain, J L Goyal, Subhadra Jalali, Rohit Saxena, Ambika Selvakumar   +4 more
doaj   +1 more source

Isogeometric Analysis of the electrophysiology in the human heart: Numerical simulation of the bidomain equations on the atria

, 2018
Luca Pegolotti, Luca Dede’, Alfio Quarteroni   +2 more
openalex   +2 more sources

921. Modulating Cellular Electrophysiology with Exogenous Ion Channel Expression Can Trigger Unexpected Cellular Remodeling [PDF]

, 2009

openalex   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Pediatric Electrophysiology

Delhi Journal of Ophthalmology, 2010
Dr. Jethani Jitendra, Dr. Thakorbhai
doaj   +1 more source

Robotic automation of “blind” and two-photon targeted patch-clamp electrophysiology in vivo

, 2021
Gema Vera Gonzalez, Phatsimo Kgwarae, Luca Annecchino, Simon R. Schultz   +3 more
openalex   +1 more source

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

ESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao, Yang Chen, Zhiyu Ling, Helmut Pürerfellner, Martin Martinek, Michael Derndorfer, Johannes Niel, Ramin Ebrahimi, Matthias Heukäufer, Sarah Janschel, Davide Di Vece, Klaus Empen, Astrid Hummel, Bishwas Chamling, Piotr Futyma, Fahim Ebrahimi, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Alexandra Schratter, Willem‐Jan Acou, Philipp Sommer, Boris Schmidt, Julian K. R. Chun, Christian Meyer, Marcus Dörr, Christian Templin, Shaojie Chen   +27 more
wiley   +1 more source

Exploring Role of Accessory Pathway Location in Wolff-Parkinson-White Syndrome in a Model of Whole Heart Electrophysiology

, 2022
Karli Gillette, Matthias A. F. Gsell, Stefan Kurath‐Koller, Martin Manninger, Anton J. Prassl, Douglas S. Scherr, Gernot Plank"   +6 more
openalex   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Correction: DICAR/DICAR-JP exerts therapeutic effects in brain stroke via the miR-361-5p/PRMT1 pathway. [PDF]

Front Pharmacol
Yu Z, Jiang A, Yang K, Zhan L, Xiang Z, Chen L, Kuai Z, Yuan Q.   +7 more
europepmc   +1 more source